roteas
berlin-chemie ag - edoxaban tosilate - stroke; venous thromboembolism - antitrombotična sredstva - preprečevanje možgansko kap in sistemsko embolijo pri odraslih bolnikih z nonvalvular atrijsko fibrilacijo (nvaf) z eno ali več dejavniki tveganja, kot so kongestivno srčno popuščanje, hipertenzijo, starost ≥ 75 let, sladkorna bolezen, predhodna kap ali prehodnih ishemičnih napad ( tia). zdravljenje globoke venske tromboze (dvt) in pljučna embolija (pe), in preprečevanje ponavljajočih se dvt in pe pri odraslih.
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastična sredstva - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
rizmoic
shionogi b.v. - naldemedine tosilate - zaprtje - zdravila za zaprtje, perifernih opioidni receptor antagonisti - rizmoic je primerna za zdravljenje opioidne povzroča zaprtje (oic) pri odraslih bolnikih, ki so že bili zdravljeni z odvajalo.
fetcroja
shionogi b.v. - cefiderocol sulfat tosilate - gram-negativne bakterijskih okužb - antibacterials za sistemsko uporabo, - fetcroja je indiciran za zdravljenje okužb zaradi aerobni gram-negativne organizmov pri odraslih z omejenimi možnostmi zdravljenja (glej točki 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - imunosupresivi - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.
hypnomidate 2 mg/ml raztopina za injiciranje
kemofarmacija d.d. - raztopina za injiciranje - etomidat
perivol combo 10 mg/2,5 mg filmsko obložene tablete
teva pharma b.v. - indapamid; perindopril - filmsko obložena tableta - indapamid 2,5 mg / 1 tableta perindopril6,816 mg / 1 tableta; perindopril 6,816 mg / 1 tableta - perindopril in diuretiki
sufentanil torrex 5 mikrogramov/ml raztopina za injiciranje ali koncentrat za raztopino za infundiranje
chiesi slovenija, d.o.o. - sufentanil - raztopina za injiciranje/infundiranje - sufentanil 5 µg / 1 ml - sufentanil